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In iron overload disorders a significant fraction of the total iron circulates in the plasma as
low molecular weight complexes not bound to transferrin, known as non-transferrin-bound
iron (NTBI). By catalyzing the formation of free radicals, NTBI accumulation results
in oxidative stress and cellular damage, being a major cause of organ toxicity. NTBI
is rapidly and preferentially cleared from circulation by the liver and the myocardium,
the main disease targets in iron overload conditions. We have recently demonstrated
that human peripheral blood T lymphocytes take up NTBI in vitro, with a pattern that
resembles that of hepatocytes. Since T lymphocytes constitute a numerically important
component of the circulating cell pool, these findings support a putative role for this
cell type in the systemic protection against iron toxicity. Here we tested the hypothesis
that the circulating peripheral blood T lymphocyte pool constitutes an important storage
compartment for NTBI and is thus a modifier of NTBI deposition in target organs. First
we show that NTBI uptake by human T lymphocytes increases the expression of the
iron-storage protein ferritin and of the iron exporter ferroportin via an IRE-dependent
mechanism. NTBI retention by T lymphocytes is shown to be critically controlled by the
hepcidin-mediated modulation of ferroportin both in vitro and in vivo. Finally, the protective
effect of T lymphocytes was tested by analyzing the patterns of iron accumulation in
the T lymphocyte-deficient mouse model Foxn1nu before and after reconstitution with
T lymphocytes by adoptive transfer. The results confirmed a significant increase of liver
and pancreas iron accumulation in T lymphocyte-deficient mice. NTBI accumulation in
the liver and spleen was prevented by reconstitution with syngeneic T lymphocytes.
Altogether, our results demonstrate that T lymphocytes are important components of
a circulating “NTBI storage compartment” and show its physiological relevance as a
modifier of tissue iron overload.
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INTRODUCTION
Iron, the most abundant transition metal in mammalian sys-
tems, is essential for various vital metabolic processes. In phys-
iologic conditions iron circulates in the plasma bound to trans-
ferrin, the main iron transporter protein, and this constitutes
the major iron source for iron-avid processes, such as ery-
thropoiesis (Hentze et al., 2010).Circulating iron which is not
bound to transferrin, heme or ferritin (here designated as non-
transferrin-bound iron—NTBI) becomes relevant in iron over-
load disorders, appearing in plasma even before transferrin
becomes fully saturated (Breuer et al., 2000; Esposito et al.,
2003).
NTBI is the main source of iron for storage in the liver
(Zimelman et al., 1977; Brissot et al., 1985). However, in con-
trast to transferrin-bound-iron, NTBI is potentially toxic, causing
cellular damage, not only of the plasma membrane but also
of various intracellular organelles, due to its involvement in
the formation of reactive oxygen species (reviewed in Brissot
et al., 2012). The uptake of NTBI by hepatocytes is thus viewed
as a clearance mechanism of potentially toxic circulating iron
that could otherwise cause damage to other cell types. Not
surprisingly, hepatocytes are the first target of iron toxicity in
situations of severe iron overload such as in HFE-Hereditary
Hemochromatosis (HFE-HH) or transfusion-dependent beta-
thalassemia. When the clearance capacity of liver is exceeded,
other organs, namely pancreas, heart or hypophysis, are also
affected by NTBI uptake and accumulation, leading to the full-
blown clinical picture of severe iron overload with liver cirrho-
sis, diabetes, cardiomyopathy, and hypogonadotrophic hypogo-
nadism (Pietrangelo, 2004). Therefore an effective removal of
circulating NTBI is a major goal in the management of iron
overload disorders.
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We have recently demonstrated that T lymphocytes are capa-
ble of taking up and accumulating the same NTBI species as
hepatocytes (Arezes et al., 2013). Together with previous evi-
dence showing that T lymphocytes synthesize ferritin in greater
amounts than non-T lymphoid cells (Dörner et al., 1980) these
results support the hypothesis that T lymphocytes may have an
important role in iron handling in the blood circulation, where
they could act as natural NTBI buffers and constitute a barrier
to protect other tissues from iron-mediated toxicity. In order to
test this hypothesis we analyze here the capacity of T lymphocytes
to store/export NTBI and assess the physiological implications of
NTBI storage by T lymphocytes as a modifier of tissue iron load.
METHODS
ISOLATION OF HUMAN PERIPHERAL BLOOD CELLS
Peripheral Blood Mononuclear cells (PBMCs) were obtained
from apparently healthy volunteer blood donors, randomly
recruited at Santo António Hospital Blood Bank (Porto, Portugal)
who gave their consent to participate in this study, approved by
the Santo António Hospital Ethical Committee. Cells were iso-
lated by gradient centrifugation over Lymphoprep (Nycomed).
After lysis of erythrocytes, cells were resuspended in RPMI
(GibcoBRL) supplemented with 10% fetal calf serum (FCS;
GibcoBRL) and plated. CD3+, CD4+, and CD8+ cells were puri-
fied from PBMCs using magnetic-activation cell sorting (MACS),
after incubation with specific microbead-conjugated antibodies
(Miltenyi Biotec), according to manufacturer’s instructions.
NTBI UPTAKE
Uptake of non-transferrin-bound iron (NTBI) was assessed using
55Fe-citrate (Grootveld et al., 1989). 55Fe-citrate stock solutions
were prepared by mixing 55FeCl3 (5–10 mCi, in 0.1M HCl;
Amersham) with unlabeled trisodium citrate, for a final citrate
concentration of 100μM. The pH was maintained at 7.4 and
solutions were allowed to rest for 20min before being diluted 33-
fold in uptake medium and added to cells. Specific activity in the
uptake medium was approximately 30 counts· min−1· pmol−1
Fe. All Fe:citrate solutions were freshly prepared before use and
discarded after each experiment. To prevent competition of T
lymphocyte-secreted transferrin for citrate-bound iron, unless
otherwise indicated cells were depleted of intracellular transfer-
rin by incubation for 1 h in serum-free RPMI. Since the estimated
time of recycling of transferrin molecules in lymphocytes is
approximately 30min (Holtzman, 1939), 1 h should suffice for
all endogenous transferrin to be secreted and, due to the absence
of extracellular iron, be prevented from being endocytosed again.
Cells were then washed and incubated with RPMI + 20% FCS
+ 5μM 55Fe-citrate (as 5μM 55FeCl3+ 100μM citric acid), at
37◦C. Given the 5μM is the typical NTBI concentration reported
in sera from thalassemia major patients (Evans et al., 2008) and
100μM citric acid falls within the interval of citrate concentra-
tions normally present in human blood plasma (Lentner, 1984).
In some experiments the iron chelator desferrioxamine (DFO;
Sigma) was added to the medium providing a final concentration
of 5μM. The pH of the incubation medium was maintained at
7.4. After incubation, cells were washed 3× with ice-cold washing
buffer (20μM DFO, in PBS, pH 7.4), lysed with a 0.1% NaOH,
0.1%Triton X-100 solution and intracellular Fe wasmeasured in a
MicroBeta Trilux β-counter (Perkin Elmer), for 1min. No signifi-
cant impact of iron treatments in cell viability was observed, using
trypan blue exclusion and maintenance of proliferative potential
following activation with anti-human anti-CD3 and anti-human
anti-CD28 for CD3+, CD4+, and CD8+T lymphocytes (Arezes
et al., 2013).
IRON EXPORT
T lymphocytes were depleted of transferrin, as described above,
and incubated, unless otherwise stated, in RPMI + 5μM Fe-
citrate (or 5μM 55Fe-citrate) + 20% FCS for 2 h. Cells were
washed 2× with washing buffer and incubated for different time-
periods in RPMI + 20% FCS + 5μM DFO (for short-term
experiments), to prevent re-uptake of exported iron, or in RPMI
+ 20% FCS (for long-term experiments). At each time-point, the
supernatants were collected and Fe was quantified as described in
NTBI uptake.
To analyze the effect of hepcidin in iron export, CD4+ and
CD8+ T lymphocytes were iron-loaded with 5μM Fe-citrate (or
5μM 55Fe-citrate), as described above, washed and incubated in
export medium (RPMI + 20% FCS) supplemented with 100 or
600 ng/ml of human synthetic hepcidin (Peptides International),
or with an equal volume of PBS (Mock), for up to 72 h. FPN lev-
els were analyzed by western blot analysis (see below) after 24 h of
incubation and intracellular 55 Fe levels were quantified after up
to 72 h of incubation.
ASSESSMENT OF LABILE IRON POOL
CD4+ and CD8+ T lymphocytes were loaded with 0.25μM of
calcein acetoxymethyl ester dye (Molecular Probes) at 37◦C for
10min, and rinsed twice with PBS to remove unincorporated
dye. These conditions were empirically determined by us to be
the most suitable for detection of iron-induced changes in cal-
cein fluorescence in PBMCs (Pinto et al., unpublished data). Cells
were then incubated with 5μM of Fe-citrate (5:100) + 20% FCS
or with 5μM of Na-citrate + 20% FCS, for up to 180min, and
the fluorescence intensity was measured at defined time points
in a fluorescent plate reader, using the conditions λexc = 488 nm
and λem = 517 nm. In some experiments, the membrane perme-
able iron chelator salicylaldehyde isonicotinoyl hydrazone (SIH,
kindly provided by Dr. Prem Ponka, McGill University, Canada)
was added to the cells (10μM final concentration) for 30min
following incubation with iron.
WESTERN BLOT ANALYSIS
Cellular extracts were isolated by the carbonate fractioning pro-
cedure, using a protocol adapted from Fujiki et al. (1982). Briefly,
harvested CD3+ lymphocytes were resuspended in 120mM
sodium carbonate supplemented with 1× Complete EDTA-free
protease inhibitor cocktail (Roche Diagnostics) and incubated
on ice for 30min. An aliquot of this suspension was saved as
total fraction. The suspensions were transferred to polycarbon-
ate tubes and centrifuged at 38,000 rpm for 45min, at 4◦C, using
a Beckman 70.1 Ti rotor. The supernatants (corresponding to the
cytoplasmic fractions) were decanted and the membrane pellets
were directly dissolved, at 65◦C, in 2× Laemmli buffer, with occa-
sional vortexing and sonication. Both total and soluble extracts
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were subjected to trichloroacetic acid precipitation and processed
for SDS-PAGE.
Cell extracts were submitted to SDS-PAGE and immunoblot-
ted for ferritin (1:1000 rabbit anti-ferritin antibody; Abcam)
and/or ferroportin (1:100 rabbit anti-ferroportin antibody;
Novus Biologicals). To control for the purity of cell fractions,
some of the extracts were hybridized with an anti-alpha 1 Na/K
ATPase antibody (1:2000; Abcam). Immuno-reactive proteins
were detected with Super Signal West Dura (Pierce). For control
of protein loading, membranes were stripped and re-hybridized
with 2μg/ml of a mouse anti-human β-actin or goat polyclonal
anti-β-actin antibodies (both from Abcam).
INTRACELLULAR Fe DETECTION BY ENERGY DISPERSIVE X-RAY
ANALYSIS
Lymphocytes were separated from monocytes in PBMCs by
allowing monocytes to adhere to the substrate for 1.5 h and
collecting the supernatant (lymphocyte-fraction). Cells were
depleted of transferrin and incubated with 5μM Fe-citrate
(5:100) for 24 h. Cells were pelleted, fixed in 2.1% glutaralde-
hyde/2% formaldehyde, washed with 0.1M phosphate buffer and
fixed for 1 hwith 1%OsO4, at 4◦C. After dehydration, the samples
were embedded in Epon 812 and ultrathin sections obtained. For
high resolution fast elemental mapping of iron-loaded lympho-
cytes, a FEI Tecnai Osiris transmission electron microscope with
ChemiSTEM technology was used. Images were recorded using
a Fischione High Angle Annular Dark Field (HAADF) detector.
A FEI super-X EDX detector was used, which provides a solid
collection angle of 0.9 sterads fully integrated with the A-TWIN
objective lens. The elemental maps were recorded with a 20μs
dwell time per pixel (spectra) with a 1K × 1K frame size (approx-
imately 20 s scan time per total frame). As plastic sections are
susceptible to shrinkage and beam damage, care was taken not to
expose the sample outside of the acquisition period by blanking
the beam when no image was acquired. Before scanning, sam-
ples were pre-eradiated in TEM mode at low magnification for
30min to reach a stable state with respect to shrinkage. During
and after the period of acquisition, the scanning area was assessed
with respect to the contrast of the image, which was taken as
a measurement of stability. No additional shrinkage or carbon
deposit occurred during the scanning period as the contrast of the
image did not change after each consecutive scan. We assumed
therefore that, after pre-eradiation, the sample was in a stable
state and no additional mass loss occurred, nor contamination
deposited on the sample during acquisition, showing that both
the beam current was acceptable for the imaging and the column
contamination was negligible. The spectra were processed using
Bruker Esprit software and the elemental map of Fe was calcu-
lated. The Energy Dispersive X-ray (EDX) maps were processed
with an opening filter followed by a Gaussian smoothing.
PLASMID CONSTRUCTION AND LUCIFERASE REPORTER ASSAY
The promoter region of FPN1 spanning from 845 bp 5′ to the
ATG codon to 50 bp after FPN1 transcription initiation site was
amplified and ligated into the pGL4 luciferase reporter vector
(Promega). pGL4 has an SV40 promoter, driving the transcrip-
tion of a luciferase chimeric mRNA which includes the FPN1
5′UTR. The FPN1 5′CAGUG IRE sequence, which is involved in
the formation of the terminal –AGU- loop (Hentze and Kuhn,
1996) was mutagenized into CCCCG with the Quickchange® II
site direct mutagenesis kit (Stratagene), according to the manu-
facturer’s protocol. The luciferase chimeric constructs containing
the wt and mutated FPN1 IREs were transfected into CD4+ and
CD8+ cells using AMAXA nucleofection, as previously described
(Pinto et al., 2010). The day after nucleofection, cells were incu-
bated for 2 h with 5μM of Fe-citrate (5:100), 5μM of Fe-citrate
(5:100) + 5μM of DFO or with RPMI, and lysed. The luciferase
activity was measured with the Dual-Luciferase Reporter Assay
System (Promega), according to the manufacturer’s instruction.
The luciferase activity was normalized with renilla luciferase
activity, used as transfection control. To control for changes
in promoter-driven transcription, luciferase mRNA levels were
assessed in parallel, with no significant changes observed between
each experimental condition (data not shown).
GENE EXPRESSION
Total RNAwas extracted using the RNeasy PlusMini kit (Qiagen),
with on-column DNA digestion (Qiagen). cDNA was synthesized
using the Superscript First-Strand Kit (Invitrogen) and qRT-PCR
was performed in an iCycler iQ5 PCR detection system (Bio-Rad),
using specific primers. Glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) and 18S rRNA mRNA expression were used as
internal controls. Since no significant differences were observed
between the two controls, all qRT-PCR results displayed were
normalized for GAPDH mRNA expression. Melting curve exper-
iments previously established that the signal for each amplicon
was specific and not derived from primer dimers. For every gene a
series of four serial dilutions was used during optimization of the
procedure. Relative expression levels were calculated as 2−CT
[CT = (Gene of interest CT − GAPDH CT)sample − (Gene
of interest CT − GAPDH CT)reference]. All experiments involving
qRT-PCR were performed at least in triplicate, with two to three
replicates each.
EXPERIMENTAL PROCEDURES WITH MOUSE MODELS
All mice models used were 7–8 week old females, maintained at
the IBMC’s Animal Care Facility. C57BL/6 mice were supplied
by Charles River or Jackson Laboratory. Foxn1nu and Foxn1+/−
were purchased from the Jackson Laboratory. All experimental
procedures were approved by and performed according to the
guidelines of the IBMC’s Animal Care Committee.
For the analysis of the effect of exogenous hepcidin on
ferroportin expression mice (n = 6) were maintained on an
iron-sufficient diet (35mg/kg chow; Harlan Laboratories) from
weaning and intravenously injected daily with mouse hepcidin
(Peptides International; 50μg/mouse in 0.3ml PBS) for 3 con-
secutive days. The control group (n = 6) was injected with PBS
only. Animals were killed 3 days after the first dose injection and
peripheral blood CD3+ cells isolated with MACS, as described
above.
To study the effect of endogenous hepcidin on ferro-
portin expression mice (n = 12/experimental condition) were
maintained on the iron-sufficient diet from weaning or on
iron-rich diet (iron-sufficient diet enriched with 2.5% iron
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carbonyl—Sigma) for 2 weeks. Mice were then intravenously
injected each 24 h with 100μl of 50μM 55Fe-citrate (50:100), to
achieve a systemic, traceable, 55Fe-citrate concentration of 5μM.
Two days after the first 55Fe injection mice were sacrificed and
livers and peripheral blood CD3+ cells were collected. Hamp1
mRNA expression was quantified in the livers by qRT-PCR and
Fpn1 expression and intracellular 55Fe accumulation quantified
in CD3+ T lymphocytes, as described above.
The effect of each diet on blood iron-related parameters was
assessed in 4 animals/experimental condition by analyzing levels
of serum iron, total iron binding capacity, and resulting trans-
ferrin saturation by standard routine procedures at the Clinical
Chemistry Laboratory of Santo António Hospital (Porto).
For the study of the modifier role of T lymphocytes in NTBI
accumulation Foxn1nu and Foxn1+/− mice were fed the iron-rich
diet for 2 weeks and intravenously injected, every 2 days, with
100μl of a 50μM 55Fe-citrate (50:100) solution, during 7 days.
The animals were killed 8 days after the first dose injection and the
livers and spleen collected. Incorporation of 55Fe was quantified
following the same procedure described in NTBI uptake.
For T lymphocyte reconstitution of Foxn1nu mice, CD3+ lym-
phocytes were isolated from the spleens of Foxn1+/− animals
(on iron-sufficient diet) using MACS, resuspended in 100μl of
endotoxin-free PBS and intravenously injected via the lateral tail
vein (5 × 106 or 15 × 106 T lymphocytes/injection) on Foxn1nu
mice that had been fed the iron-sufficient diet from weaning
or the iron-rich diet for 2 weeks. Control (Mock) animals were
injected with an equal volume of PBS. The purity of the T lym-
phocyte fraction was verified by FACS, using an FITC-labeled
anti-mouse CD3 antibody (BD Pharmingen) and confirmed to
be >93%. Immediately following T lymphocyte transfer mice on
iron-rich diets were injected with 100μl of a 50μM 55Fe-citrate
(50:100) solution, which was repeated 24 h later. Forty-eight
hours after T lymphocyte transfer all mice were sacrificed and the
levels of 55Fe in the liver and spleen quantified. For quantification
of hemosiderin deposition, livers were fixed in 4% formalde-
hyde, embedded in paraffin, mounted onto slides, and stained
with Prussian blue and hematoxylin-eosin counterstain, using
standard procedures. Hemosiderin was detected using the Perls’
Prussian Blue method.
STATISTICAL ANALYSIS
The results are expressed as mean values ± 1 standard devia-
tion (SD). Statistical differences between means were calculated
using the Student’s unpaired t-test. For experiments involving
multiple comparisons, One-Way or Two-Way analysis of variance
(ANOVA) was used. When significant differences were detected,
the data were re-analyzed using the Fisher’s least significance dif-
ference test. Statistical significance was set at P < 0.05. All statis-
tical analyses were performed using STATGRAPHICS Centurion
XV (Statpoint Technologies).
RESULTS
NTBI ACCUMULATION BY HUMAN PERIPHERAL BLOOD T
LYMPHOCYTES
To test the ability of T lymphocytes to store iron acquired as
NTBI, CD4+, and CD8+ T lymphocytes were incubated with
5μM of Fe-citrate for 0–12 h and the expression of the iron
storage protein Ferritin H (FTH) quantified byWestern blot anal-
ysis. We observed that both T lymphocyte populations increase
FTH levels in response to Fe-citrate, an effect abrogated by the
supplementation of the culture medium with 5μM desferriox-
amine (DFO) (Figure 1A). The changes in FTH expression are
in agreement with our previous results showing that a plateau in
intracellular iron is reached earlier than 6 h in the presence of a
constant NTBI concentration (Arezes et al., 2013) and suggest the
capacity of the cells to store a fraction of the intracellular iron in
the Ferritin core.
The fraction of iron that is not included in the storage com-
partment should be associated with proteins other than ferritin
(functional iron) or enter the transit iron pool, also known as
Labile Iron Pool (LIP). Using the calcein assay, which is based
on the quenching of the fluorescence of the permeant calcein
acetoxymethyl ester by iron, we assessed the contribution of
NTBI to the LIP in T lymphocytes. We observed a significant
time-dependent decrease in the fluorescence of intracellular cal-
cein exclusively for T lymphocyte populations exposed to 5μM
of Fe-citrate, indicating an increase in intracellular labile iron
(Figure 1B). The difference between iron-loaded and control cells
reaches its maximum values after 30min of incubation, suggest-
ing that an equilibrium is reached at this point between the
formation of new labile iron and incorporation of iron in the stor-
age pool + iron export. Validation of the specific effect of iron in
the fluorescence quenching of calcein was obtained by recover-
ing fluorescence exclusively on iron-treated cells upon incubation
with the membrane-permeable iron chelator SIH.
To further characterize intracellular iron accumulation in T
lymphocytes we used EDX analysis to generate maps of intra-
cellular iron distribution in ultrathin sections of cells incubated
with 5μM Fe-citrate (5:100) for 24 h. Using this approach we
confirmed that T lymphocytes accumulate iron from Fe-citrate
and showed that intracellular iron shows distinct distribution
patterns, ranging from homogeneously-sized particles with an
area of approximately 20 nm2 to large aggregates with a more
amorphous appearance, some of which >1μm in diameter
(Figure 2A). A more detailed analysis of the iron-rich structures
showed that their iron content is highly variable (Figures 2B,C),
revealing also a consistent enrichment in nitrogen, oxygen, phos-
phorous, and chlorine (Figure 2C), which suggests the associ-
ation of intracellular iron with other compounds, that could
include phosphate and proteins.
NTBI EXPORT BY HUMAN PERIPHERAL BLOOD T LYMPHOCYTES
Iron export
In order to have a relevant role as a component of the iron storage
compartment, T lymphocytes would need to selectively retain or,
alternatively, export intracellular iron acquired as NTBI accord-
ing to systemic signals. To test this hypothesis we analyzed the
export of iron acquired as Fe-citrate by T lymphocytes. CD4+
and CD8+ T cells were exposed to 5μM Fe-citrate for 2 h, a
time point at which cells have reached the maximum iron content
(Arezes et al., 2013), and allowed to export iron into an iron-
free medium for up to 6 h. We observed that iron export by T
lymphocytes follows a linear pattern, with a delay in CD8+ cells,
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FIGURE 1 | NTBI storage by T lymphocytes. (A) Regulation of Ferritin H
expression by NTBI in T lymphocyte populations. Western blot quantification
of Ferritin H (FTH) expression in CD4+ and CD8+ cells incubated with 5μM
of Fe-citrate (upper panel) or Fe-citrate + 5μM DFO (middle panel) for 0–12 h.
β-actin expression was used as loading control. Images are representative of
three experiments without significant inter-experimental variation. Bottom
panel: Scanning densitometry of FTH Western blot. Data are normalized for
β-actin levels and are expressed as arbitrary units (AU). ∗P < 0.05 and
∗∗P < 0.005 (One-Way ANOVA) between relative FTH levels at 0 h and
posterior time-points, for each population and experimental condition.
(B) Regulation of the Labile Iron Pool by NTBI in T lymphocyte populations.
Upper panel: intracellular calcein fluorescence in CD4+ and CD8+ T
lymphocytes incubated with 5μM of Fe-citrate or 5μM of Na-citrate (Mock).
Each point represents the average (n = 3) ± 1 SD. ∗∗P < 0.005 (One-Way
ANOVA) between fluorescence levels at 0 h and posterior time-points, for
each population and experimental condition. Bottom panel: following
incubation with 5μM of Fe-citrate for 180min, 10μM of SIH were added to
cells (arrow) and changes in calcein fluorescence monitored for 30min. Data
from a representative experiment (n = 3), with minimum inter-experimental
variation.
which only match CD4+ lymphocyte’s export rate after 60min of
export (Figure 3A). After 60min in an iron-free medium, iron
export by T lymphocytes corresponds to approximately 3% of
intracellular levels, demonstrating a slow release of iron acquired
as NTBI by these cells. This is confirmed by the quantification
of intracellular 55Fe remaining in both T lymphocyte populations
throughout time, which further shows that, after 72 h of export, T
lymphocytes maintain approximately 20% of the initial iron load
acquired as NTBI (Figure 3B).
Role of FPN1
The trans-membrane domain protein SLC40A1 (ferroportin,
FPN1) is the only known cellular iron exporter (Donovan et al.,
2005). Little is known about the expression of FPN1 by T lympho-
cytes andeven lesson its regulationbycellular andsystemic stimuli.
We observed clear expression of the protein in membrane extracts
of untreated CD3+ cells, while it was undetectable in the cytosolic
fraction (Figure 3C). The high purity of the cell fractionation
was further confirmed by the clear detection of the plasma mem-
brane marker protein alpha 1 sodium potassium ATPase in one of
the membrane extracts depicted in Figure 3C, with only residual
detection in the cytoplasmic extracts (Supplementary Figure 1).
Expression of FPN1 increased significantly in T lymphocytes after
exposure to 5μM Fe-citrate for 3 h and are maintained at least
up to 6 h of incubation (Figure 3D). No changes in FPN1 were
observed in cells supplemented with PBS, confirming the role
of iron in the observed FPN1 increase. Altogether, these results
suggest the involvement of ferroportin in the trans-membranar
transport of iron in T lymphocytes.
Although 5μM Fe-citrate is in the range of the NTBI concen-
trations commonly detected in iron overload disorders, in severe
cases of iron overload values as high as 30μMhave been reported
(Batey et al., 1980). To test whether iron export by T lymphocytes
is dependent on the extracellular NTBI concentration, cells were
incubatedwith increasing doses of Fe-citrate (XFe:100μMcitrate)
for 2 h and allowed to export iron into an iron-free medium. We
observed a dose-dependent increase in iron export with increas-
ing NTBI concentrations (Figure 3E). Interestingly, the increase
in iron export cannot be accounted by augmented FPN1 lev-
els, as no significant changes in FPN1 expression were detected
between incubations with 20 and 100μM Fe-citrate (Figure 3F).
The increased iron export might thus be caused by an increase in
the flux of Fe(II) ions transported by each FPN1 molecule rather
than to a augmentednumber of FPN1molecules at the cell surface.
In hepatocytes and macrophages intracellular iron regu-
lates FPN1 translation, by a mechanism involving the IRP/IRE
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FIGURE 2 | Intracellular iron detection with EDX. (A) Energy dispersive
X-ray analysis of a representative image showing intracellular cytoplasmic
iron in a CD3+ cell. White represents iron. Numbered areas analyzed for
elemental composition; “1” represents the total area depicted. (B)
Elemental composition of the four areas depicted in (A) with the peak
corresponding to iron highlighted (Fe). Peak height is proportional to the
respective element’s abundance. Values are depicted in counts per pix per
second per ev (cps/ev). (C) Relative (%) elemental composition of regions
signaled in (A); C = carbon, N = nitrogen, O = oxygen, P = phosphorous,
S = sulfur, Cl = chlorine, Fe = iron.
machinery (Lymboussaki et al., 2003). To test if this mechanism
is involved in the response of FPN1 to NTBI in T lymphocytes,
we cloned the FPN1-5′UTR in the pGL4 vector, in which a SV40
promoter drives transcription to produce a luciferase chimeric
mRNA with the FPN1-5′UTR as its 5′UTR. In CD4+ and CD8+
cells nucleofected with the FPN1/luciferase construct, the expres-
sion of luciferase increased approximately 2-fold following incu-
bation with 5μM Fe-citrate for 2 h (Figure 3G), in comparison
with cells incubated in iron-free medium or in medium contain-
ing Fe-citrate + DFO. This result matches the increase in FPN1
observed by immuno-blot (Figure 3D). Sequential mutagenesis
of the FPN1-5′-UTR previously shown to impair IRP binding
to FPN1-IRE (Hentze and Kuhn, 1996) resulted in a significant
increase (approximately 4-fold) of the basal FPN1 expression in
the two cell populations and, importantly, abrogated the response
to Fe-citrate. Together, these results confirm the involvement
of the IRE/IRP system in the NTBI-mediated increase in FPN1
expression. This post-transcriptional mechanism is probably the
major contributor to the FPN1 increase in response to NTBI, as
no changes in FPN1mRNA expression were observed in response
to 5μM Fe-citrate (Supplementary Figure 2), arguing against a
transcriptional regulation of FPN1 by NTBI in these cells.
The hepcidin-FPN1 axis
Besides the IRE/IRP translational regulation, FPN1 expression
is also regulated post-translationally by the hormone hepcidin,
which is secreted mainly by the liver in response to several
stimuli, including iron overload (Nemeth et al., 2004). Since
the characterization of iron export above was performed in
a hepcidin-free medium, which does not correspond to most
in vivo situations in which NTBI is present, we re-analyzed iron
export by T lymphocytes, using the same experimental setup,
in the presence of human synthetic hepcidin at doses present
in human serum in normal and in iron-overload conditions
(Ganz et al., 2008). Exogenous hepcidin caused a dose-dependent
decrease in FPN1 levels in both T lymphocyte populations
(Figure 4A) together with a significant dose-dependent increase
in iron retention over 72 h (Figure 4B). To control for possible
hepcidin-mediated changes in NTBI uptake that could explain the
iron-retention results we measured iron uptake in T lymphocytes
incubated with 5μM of 55Fe-citrate for 30min, in the pres-
ence of human hepcidin. No significant differences were found
between hepcidin-supplemented and hepcidin-free conditions
(Supplementary Figure 3), which leads us to ascribe the effect of
hepcidin exclusively on iron export.
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FIGURE 3 | Iron export by T lymphocytes. (A) Time-dependent iron export
by T lymphocytes. Each point is a mean value (n = 3) ± 1 SD. (B) Impact of
iron export in intracellular Fe levels. Each point is a mean value ± 1 SD of two
experiments each with three replicates. (C) Ferroportin (FPN1) expression in
CD3+ T lymphocytes. Membrane (M), cytoplasmic (C), and total (T) extracts
of CD3+ cells were blotted and membranes incubated with anti-FPN1 and
anti-β-actin antibodies. Results obtained with CD3+ cells from three different
blood donors are presented. (D) Western blot quantification of FPN1
expression in CD4+ and CD8+ T lymphocytes incubated with 5μM of
Fe-citrate (upper panel) or PBS (middle panel) for 0–6 h. β-actin expression
was used as loading control. Images are representative of four experiments
without significant inter-experimental variation. Bottom panel: Scanning
densitometry of FPN1 Western blots. Data are normalized for β-actin levels
and are expressed as arbitrary units (AU); ∗P < 0.05 (One-Way ANOVA)
between relative FPN1 levels at 0 h and posterior time-points, for each
population and experimental condition. (E) Dose-dependent iron export by
T lymphocytes. Each point is the mean of two experiments with two
replicates each. (F) Western blot quantification of FPN1 expression in
T lymphocytes incubated with different Fe-citrate concentrations. β-actin
expression was used as loading control. Images are representative of three
experiments without significant inter-experimental variation. Bottom panel:
Scanning densitometry of FPN1 Western blot. Data are normalized for β-actin
levels and are expressed as arbitrary units (AU). ∗P < 0.05 (One-Way ANOVA)
between relative FPN1 levels at 0 h and posterior time-points. (G)
Involvement of the IRE/IRP system in the NTBI-induced modulation of FPN1
in T lymphocytes. Cells were transfected with a chimeric construct including
wild-type (WT) or mutated (Mut) FPN1-IRE and incubated with Fe-citrate
(Fe-Cit), Fe-Cit + DFO or RPMI (No-Fe) and the luciferase activity quantified.
Each point is a mean value (n = 3) ± 1 SD. ∗P < 0.05 (One-Way ANOVA) for
each experimental condition relative to WT IRE-No Fe control.
The previous results show that iron export by T lympho-
cytes is virtually totally abolished following exposure to hepcidin
levels typically present in iron overload and inflammation con-
texts (600 ng/ml), suggesting that systemic hepcidin levels may
significantly modify the amount of iron which is released by T
lymphocytes back into the circulation. To test this hypothesis,
C57Bl/6 mice were intravenously injected with mouse synthetic
hepcidin, or PBS, for 3 consecutive days and Fpn1 expression
quantified in peripheral blood CD3+ cells. Confirming the ex
vivo results, hepcidin injections caused a marked decrease of
Fpn1 in mouse peripheral blood T lymphocytes (Figure 4C).
To further explore the involvement of systemic hepcidin in the
control of iron export by T lymphocytes, C57Bl/6 mice were
fed an iron-rich diet for 2 weeks, in order to saturate transfer-
rin and induce an increase in systemic hepcidin levels. Controls
were fed a diet previously shown to be iron-sufficient (Ramos
et al., 2011). As expected, dietary iron induced a significant
increase in serum iron parameters, including transferrin satu-
ration, which increased from 53 ± 8% in control animals to
87 ± 4% in mice on iron-rich diet (Table 1). Two weeks later,
all mice were intravenously injected with 100μl of 50μM 55Fe-
citrate (50:100), to achieve a systemic 55Fe-citrate concentration
of 5μM. Analysis of the animals 48 h after injection showed, as
expected, a significant increase (about 20-fold) of liver Hamp1
mRNA levels in iron-loaded mice (Figure 4D). Most impor-
tantly, peripheral blood CD3+ cells in iron-overloaded mice had
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FIGURE 4 | Modulation of FPN1 expression and iron export by hepcidin
in human and mouse T lymphocytes. (A) Modulation of Ferroportin (FPN1)
by hepcidin in human T lymphocytes. Western blot quantification of FPN1 in
CD4+ and CD8+ T lymphocytes incubated with the indicated concentrations
(ng/ml) of hepcidin for 24 h. β-actin expression was used as loading control.
Images are representative of three experiments without significant
inter-experimental variation. Bottom panel: Scanning densitometry of FPN1
Western blot. Data are normalized for β-actin levels and are expressed as
arbitrary units (AU). ∗∗P < 0.005 (One-Way ANOVA) between relative FPN1
levels in Mock- and hepcidin-supplemented conditions. (B) Modulation of iron
retention by hepcidin. Each point represents the mean value ± 1 SD (n = 3) of
intracellular iron in human T lymphocytes incubated with 5μM of 55Fe-citrate
for 2 h and allowed to export iron in an NTBI-free medium, in the presence
(100 or 600 ng/ml) or absence (Mock) of hepcidin, for up to 72 h. ∗P < 0.05
and ∗∗P < 0.005 (One-Way ANOVA) between the time-dependent distribution
of iron levels in each experimental condition and the no-iron control, for each
cell population. (C,D) In vivo modulation of mFpn1 by hepcidin and iron in
mice T lymphocytes. (C) Western blot quantification of mFpn1 expression in
T lymphocytes from C57Bl/6 mice injected with synthetic mouse hepcidin (+
Hepcidin) or with PBS (Mock). β-actin expression was used as loading
control. Each lane represents a pool of CD3+ cells from 3 animals. (D) Upper
panel: qRT-PCR quantification of Hamp1 expression in livers (n = 3 per bar) of
C57Bl/6 mice fed iron-rich (+Fe) or iron-sufficient (Mock) diets followed by
injection of 50μM 55Fe-citrate. Western blot quantification of Fpn1
expression (middle panel) and intracellular 55Fe quantification (bottom panel)
in peripheral blood T lymphocytes collected from the same animals. In middle
and bottom panels data from each lane represents a pool of T lymphocytes
from 6 animals. ∗∗P < 0.005 (Student’s t-test).
a marked reduction in Fpn1 expression and significantly higher
intracellular 55Fe levels. Altogether, these results demonstrate,
in vivo, the role of hepcidin in the control of NTBI retention vs.
export by peripheral blood T lymphocytes.
Systemic impact of NTBI uptake by T lymphocytes
The results above led us to hypothesize that NTBI storage by
T lymphocytes may represent a modifier of accumulation of
this iron form in target organs. To test this hypothesis, we first
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Table 1 | Serum iron-related parameters in mice fed iron-sufficient
and iron-enriched diets.
Blood iron-related UIBC TIBC Serum Fe Tf
parameters/ (µg/dl) (µg/dl) (µg/dl) saturation
Experimental (%)
condition
Fe-sufficient diet 146.25 ± 53.5 303.75 ± 60.2 158 ± 16 53 ± 8
Fe-enriched diet 46.25 ± 15.2 358.25 ± 11.1 312 ± 6 87 ± 4
UIBC, unsaturated iron-binding capacity; TIBC, total iron-binding capacity; Tf,
transferrin.
compared iron accumulation in target organs of T lymphocyte-
deficient Foxn1nu and T lymphocyte-normal Foxn1+/− mice fed
an iron-rich diet in which traceable NTBI was generated by
intravenous injection of 55Fe-citrate. We observed significantly
higher 55Fe levels in the livers than in the other organs analyzed,
confirming that the traceable iron in our experimental setup
mostly incorporates the NTBI pool (Figure 5A). In accordance
with previous results obtained with other lymphocyte-deficient
models (de Sousa et al., 1994; Santos et al., 2000; Cardoso et al.,
2002), there is a significant increase in iron accumulation in liv-
ers and pancreas of Foxn1nu mice, in comparison with Foxn1+/−
controls. No significant differences were observed for the spleen
and heart. Next the specific involvement of T lymphocytes in this
result was tested by reconstituting a group of Foxn1nu animals
in iron-rich diets with 5 × 106 or 15 × 106 T lymphocytes iso-
lated from the spleens of histocompatible Foxn1+/− animals on
iron-normal diets. In Foxn1nu animals reconstituted with 5 × 106
T lymphocytes liver iron levels are approximately 20% lower
than in non-reconstituted controls, a difference which increases
to approximately 35% when 15 × 106 T lymphocytes were used
(Figure 5B). The same result, although with lower statistical sig-
nificance, was observed for the spleen. Histological analysis of
Foxn1nu liver sections showed no significant hemosiderin depo-
sition in the livers of Foxn1nu or T lymphocyte-reconstituted
Foxn1nu mice on iron-normal diets (Figure 5C), but high levels
of stainable iron were detected in the liver parenchyma of Foxn1nu
iron-loaded animals. Confirming the results obtained with 55Fe,
reconstitution of the T lymphocyte pool with 15 × 106 T lym-
phocytes reduced the levels of liver stainable iron. Changes in
liver iron deposition in response to T lymphocyte reconstitution
cannot be ascribed to alterations in intestinal iron absorption or
iron retention induced by hepcidin, since no changes in hepcidin
mRNA levels were observed in response to T lymphocyte transfer
(Supplementary Figure 4). Altogether, these results demonstrate
the physiological role of T lymphocytes as modifiers of NTBI
deposition in target organs, which schematic representation is
proposed in Figure 6.
DISCUSSION
The major players and mechanisms in systemic iron home-
ostasis classically consider four major compartments, involving
particular cell types. The functional compartment (erythroid pre-
cursors or other proliferating cell pools), the uptake compartment
(enterocytes), the recycling compartment (spleen macrophages),
and the storage compartment (hepatocytes and macrophages).
The described model, however, neglects the contribution of all
remaining cell types which may contribute to the fine-tuning of
the homeostasis of this essential yet dangerous element. In this
work we demonstrate the capacity of peripheral blood circulating
T lymphocytes to store iron acquired in the form of NTBI,
which is the iron presentation associated with toxicity in iron-
overload disorders. In addition, we describe how this capacity,
modulated by the hepcidin-ferroportin axis, has important phys-
iological consequences. By doing so, we introduce the concept of
the “circulating storage compartment” and establish a role for T
lymphocytes as important players in this new component of iron
homeostasis.
The capacity to take up NTBI has been demonstrated for
a variety of circulating blood cells, including reticulocytes and
erythrocytes (Zhang et al., 2008; Prus and Fibach, 2011), lym-
phocytes (Arezes et al., 2013), monocytes, eosinophils, basophils,
neutrophils, and platelets (Pinto et al., unpublished results and
Hausmann et al., 1988). It is thus possible that all or at least some
of these cell types play a role in the buffering of NTBI from tar-
get organs. That will depend not only on the quantitative NTBI
retention capacity but also on the selectivity of each cell type for
the NTBI species present in circulation in each particular con-
text. Among these cells, T lymphocytes constitute a particularly
interesting population and an obvious target for analysis. They
are known for some time to be negatively associated with the
severity of iron overload both in mice (de Sousa et al., 1994;
Santos et al., 1996; Cardoso et al., 2002) and in HFE-HH human
patients (Porto et al., 1997; Barton et al., 2005; Cruz et al., 2006),
and we show now that they possess the necessary features to be
acknowledged as important players in NTBI homeostasis:
FAST AND SELECTIVE NTBI IMPORT
NTBI clearance from the circulation has been previously
described to be a rapid and efficient procedure. Once in contact
with the liver, NTBI is cleared with a half-life of<30 s, in compar-
ison with approximately 50min for TF-bound iron (Brissot et al.,
1985). The same rapid pattern of NTBI uptake was previously
described by us for T lymphocytes, although these cells show
a lower capacity to accumulate NTBI than hepatocytes (Parkes
et al., 1995; Arezes et al., 2013).
IRON UTILIZATION/STORAGE AFTER EXPOSURE TO NTBI
We show here an increase in the LIP of T lymphocytes exposed to
NTBI. The nature and distribution of LIP in any cellular system
remains essentially unknown. Our results with EDX analysis in T
lymphocytes show a heterogeneous distribution of intracellular
iron and the enrichment of iron-rich structures with nitrogen,
oxygen, phosphorous and chlorine, suggesting the association
of iron with compounds such as phosphate and proteins. This
association may result in protection of the cell from oxidative
damage mediated by labile iron, an hypothesis supported by
previous studies showing the lack of NTBI-induced ROS in Jurkat
cells that accumulate NTBI as phosphate nanoparticles (Jhurry
et al., 2012, 2013).
Intracellular iron incorporated in the LIP fraction can either be
utilized in iron-requiring processes or stored, mostly associated
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FIGURE 5 | NTBI accumulation in T lymphocyte-deficient and T
lymphocyte-reconstituted mice. (A) 55Fe levels in livers, pancreas, spleens,
and hearts of Foxn+/− and Foxn1nu mice fed an iron-rich diet and injected
with 50μM 55Fe-citrate. Each dot represents an animal. ∗P < 0.05, Foxn1nu
vs. the corresponding tissue of Foxn+/− mice; Students’ t-test. (B) 55Fe
levels in livers and spleen of Foxn1nu mice fed an iron-rich diet + injection of
50μM 55Fe-citrate and reconstituted with 5 × 106 or 15 × 106 CD3+ T
lymphocytes or injected with PBS (Mock). Data are depicted as lower
quartile, median, and upper quartile (boxes) and minimum/maximum ranges
(whiskers; ∗P < 0.05, ∗∗P < 0.005 control vs. reconstituted animals;
Students’ t-test). (C) Perls’ Prussian blue staining of iron (blue) in livers of
Foxn1nu mice + iron-sufficient diet (upper left panel), Foxn1nu mice +
iron-sufficient diet reconstituted with 15 × 106 T lymphocytes (upper right
panel), Foxn1nu mice + iron-rich diet (bottom left panel) and Foxn1nu mice +
iron-rich diet reconstituted with 15 × 106 T lymphocytes (bottom right panel).
Magnification = 100×.
with ferritin. Evidence that T lymphocytes are equipped to
integrate iron acquired as NTBI in the cell’s metabolism is pro-
vided in our previous study showing an increase in activation-
mediated proliferation in response to this iron form (Arezes et al.,
2013). Evidence for iron storage is provided here by the observa-
tion of an NTBI-induced up-regulation of the ferritin levels in T
lymphocytes, suggesting an increase in the iron-storage capacity
of these cells in response to NTBI uptake. The few studies previ-
ously addressing the response of ferritin to NTBI in lymphocytes
show disparate results and their interpretation is hindered by
the use of distinct iron donors, most of them non-physiological,
and of frequently non-physiological NTBI concentrations (Pelosi
et al., 1986; Seligman et al., 1991; Djeha and Brock, 1992;
Chitambar and Wereley, 2001). We believe that the use of fer-
ric citrate as iron donor, the maintenance of citrate concentra-
tions between the physiological interval of 60–140μM (Lentner,
1984) and the use of iron concentrations in the range of those
found commonly in iron overload situations (Evans et al., 2008)
constitute the correct experimental setup and should become the
standard procedure for future studies involving biological systems
and NTBI.
NTBI EXPORT IN A REGULATED MANNER
We demonstrate that iron acquired as NTBI by T lympho-
cytes is exported via ferroportin in an IRP/IRE-regulated man-
ner. In vitro, and in the absence of exogenous hepcidin,
both T lymphocyte populations (CD4+ and CD8+) export
approximately 3% per hour of intracellular Fe, which com-
pares with what has been reported for monocytic/macrophagic
cell lines—approximately 6% (Ludwiczek et al., 2003). However,
these values might not represent the in vivo iron export of
these cells, as the demonstration of the modulation of T lym-
phocyte ferroportin, and concomitant Fe export, by circulating
hepcidin, places the effective iron export of T lymphocytes,
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FIGURE 6 | Proposed model of NTBI storage and further utilization for
cell growth. When in contact with hepatocytes, NTBI ( ) is rapidly taken up
and stored, this being classically accepted as the most effective
mechanism of NTBI clearance from the blood. NTBI in the blood stream is
taken up by T lymphocytes, where it integrates the intracellular labile iron
pool ( ) and the ferritin stores ( ). These cells, and possibly others,
constitute the “circulating” iron storage compartment. When the
circulating and liver NTBI clearance capacities are exceeded, other cell
types, such as pancreatic beta cells or cardiomyocytes, also take up NTBI,
with iron accumulation in the respective organs (pancreas, heart). Besides
constituting a first line “safe” deposit of iron, T lymphocytes (and possibly
other circulating cells) could also contribute to iron distribution and delivery
to other cells and tissues, either in normal physiological (homeostatic
erythroid/lymphoid proliferation) or pathological conditions (stress
erythropoiesis, inflammation, tumor growth). T lymphocyte-derived iron
uptake by target cells could occur as transferrin-bound iron (Fe-Tf) or as
NTBI, which could be exported directly via ferroportin or, eventually, by
ferritin secretion, as proposed earlier (Dörner et al., 1980).
and thus their NTBI storage capacity, under the systemic con-
trol. This finding, together with a previous study reporting
the expression of ferroportin by erythroblasts and its modula-
tion by hepcidin (Zhang et al., 2011), places this protein in an
even more central place in iron homeostasis and highlights the
need to consider the contribution of other “non-classical” play-
ers in pathologies associated with inappropriate expression of
hepcidin. Nevertheless, these results do not preclude the exis-
tence of alternative iron export pathways, such as iron exported
in association with ferritin, a mechanism first proposed for
T lymphocytes (Dörner et al., 1980) and later described for
macrophages (Cohen et al., 2010) and hepatocytes (Nemeth,
pers. comm.).
Our results show that CD4+ and CD8+ T lymphocytes do
not differ significantly in the export/retention of iron acquired
as NTBI. Previous results showing iron overload in mice defi-
cient in CD8+ T lymphocytes (de Sousa et al., 1994; Santos et al.,
1996; Cardoso et al., 2002) and the inverse correlation recurrently
observed between CD8+ T lymphocyte numbers and the sever-
ity of iron overload in HFE-HH human patients (Porto et al.,
1997; Barton et al., 2005; Cruz et al., 2006) might thus need
to be reinterpreted not as an indication that CD8+ T cells play
a unique role in iron homeostasis but instead that the lack or
a reduction in number of these cells affects the fine-tuning of
iron homeostasis, namely NTBI distribution. This conclusion is
supported by previous results showing higher severity of iron
overload in β2m−Rag1− mice—deficient in CD4+ and CD8+
T lymphocytes and B lymphocytes—than in β2m− animals—
deficient in CD8+ T lymphocytes (Santos et al., 2000). The
lack of differences in NTBI retention between CD4+ and CD8+
cells is also in agreement with our previous findings of sim-
ilar NTBI uptake by the two cell types (Arezes et al., 2013).
In that study we did not find evidence for the involvement
of neither DMT1 nor ZIP14, the most likely NTBI transporter
candidates (Trinder et al., 2000; Liuzzi et al., 2006), leaving
the door open for the identification of a still elusive trans-
port mechanism.
Here we demonstrate the ability of transferred T lympho-
cytes to retain circulating NTBI and thus reduce its accumu-
lation in the liver and spleen. This result cannot be ascribed
to hepcidin-mediated changes in iron metabolism induced by
T lymphocyte transfer, since (1) no significant differences in
liver hepcidin expression were found in response to transfer-
ence alone and (2) no visible changes in liver iron deposition
were observed between non-transferred and transferred animals
on an iron-sufficient diet. This is in agreement with a previous
report showing the absence of alterations in iron homeostasis
in NOD/SCID mice transferred with syngeneic T lymphocytes
(Bair et al., 2009). The lack of increased iron deposition in the
livers of T lymphocyte-depleted animals on an iron sufficient
diet also illustrates one important conclusion from our results
which is that the absence of T lymphocytes is not the cause of
iron overload and NTBI accumulation but instead that, by act-
ing as a first line of retention, T lymphocytes are modifiers of
NTBI accumulation when this iron form is present in the blood
circulation.
At the present time we cannot exclude the possibility that
other mechanisms besides NTBI storage could, at least in
part, underlie the observed reduction in organ iron deposi-
tion. An alternative explanation is the synthesis of cytokines
or other molecules by T lymphocytes upon contact with iron,
which could in turn impact, directly or indirectly, on the han-
dling of iron by other tissue/cell types, as previously reported
(Ten Elshof et al., 1999; Meyer et al., 2002; Sharma et al.,
2009).
The capacity of T lymphocytes to store and release NTBI
may have implications beyond their capacity to modify sys-
temic iron overload. It is reasonable to consider that at the
local tissue level they could interfere with the availability of
iron in the extracellular milieu (as proposed in Figure 6) and
thus influence the growth rate of adjacent cells, playing a role
in normal cell/tumor growth and tissue remodeling, such as
already demonstrated for polarized M2 macrophages (Recalcati
et al., 2012). This report does not address the impact of NTBI
uptake in the in vivo T lymphocyte metabolism besides iron
storage and export. Although in our experimental conditions T
lymphocytes retained their viability and proliferation potential,
at this point we cannot exclude the possibility that accumu-
lation of iron from NTBI may interfere with other normal T
lymphocyte functions and immune surveillance. Previous stud-
ies have shown that lymphocytes from iron-overloaded ani-
mals have a reduced capacity to generate allo-specific cyto-
toxic responses (Good et al., 1987) and that ferric salts can
alter a variety of lymphocyte functions in vitro (Nishiya et al.,
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1980; Brock, 1981; Bryan et al., 1981, 1986; van Asbeck et al.,
1982; Bryan and Leech, 1983). In addition, specific abnormal-
ities in CD8+ T lymphocyte functions have been described in
HFE-HH patients, including defective lymphocyte-specific pro-
tein tyrosine kinase (p56lck) activity, decreased cytotoxic activ-
ity, a decreased number of CD8+ T cells expressing the co-
stimulatory molecule CD28, but also an increased number of
CD8+ T cells lacking CD28, and an abnormally high percent-
age of HLA-DR-positive activated T cells (Arosa et al., 1994, 1997;
Arosa, 2002).
In conclusion, this work demonstrates that T lymphocytes are
important components of a circulating NTBI storage compart-
ment and show its physiological relevance as modifiers of tissue
iron overload. On a broader scope, it provides a mechanistic sup-
port for the possibility of circulating T lymphocytes acting in vivo
as a key component in systemic iron homeostasis, by playing a
role in the surveillance of iron toxicity and of its possible use by
pathogens and tumor cells, as first postulated 32 years ago (de
Sousa, 1981).
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Supplementary Figure 1 | Assessment of the purity of the plasma
membrane fraction from human CD3+ cells. Membrane (M; n = 1),
cytoplasmic (C; n = 3), and total (T; n = 1) protein fractions from human
CD3+ cells were blotted and the membrane incubated with the plasma
membrane marker anti-alpha 1 Na/K ATPase antibody.
Supplementary Figure 2 | Effect of NTBI on FPN1 mRNA expression in
human peripheral blood T lymphocytes. qRT-PCR analysis of FPN1 mRNA
expression in human peripheral blood CD4+ and CD8+ T lymphocytes
incubated with 5μM Fe-citrate or PBS for up to 6 h. Data are depicted as
fold change relative to FPN1 mRNA levels at 0 h for each cell population.
Experiments were performed three times with 2 replicates per
experiment. Each bar represents the mean ± 1 SD.
Supplementary Figure 3 | Effect of hepcidin on Fe-citrate uptake by T
lymphocytes. Intracellular 55Fe levels in CD4+ and CD8+ T-lymphocytes
incubated with 5μM of 55Fe-citrate, for 30min, in the presence of 100 or
600 ng/ml of human synthetic hepcidin. Mock controls were incubated
without hepcidin. Experiments were performed three times with 3
replicates per experiment. Each point represents the mean ± 1 SD.
Supplementary Figure 4 | Effect of T lymphocyte reconstitution on Hamp1
mRNA expression on Foxn1nu mice. qRT-PCR quantification of Hamp1
mRNA expression on livers of Foxn1nu mice on iron-rich (+NTBI) or
iron-sufficient (no NTBI) diets I.V. injected with 15 × 106 CD3+ T
lymphocytes or with PBS (Mock). Data are depicted as fold change
relative to FPN1 mRNA levels of Mock animals on iron-sufficient diet. Each
bar represents the mean ± 1 SD of the values obtained for three animals.
Statistical analysis was performed using One-Way ANOVA.
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